MedPath

APO-LAMIVUDINE

APO-LAMIVUDINE

Approved
DIN Number

02369052

Drug Class

Human

Market Date

May 18, 2012

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02369052
AIG Number0128157001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF05 LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.